Bavarian Nordic AS (OTCPK:BVNRY)
$ 9.8275 0.0375 (0.38%) Market Cap: 2.32 Bil Enterprise Value: 2.01 Bil PE Ratio: 21.99 PB Ratio: 1.52 GF Score: 76/100

Bavarian Nordic A/S - Special Call Transcript

Oct 21, 2019 / 08:00AM GMT
Release Date Price: $8.83
Operator

Ladies and gentlemen, welcome to the acquisition of 2 commercial vaccine conference call. (Operator Instructions) I would now like to turn the conference over to your host, Mr. Rolf Sørensen. Please go ahead.

Rolf Sass SÃ;rensen;S;VP of IR;Communications
Bavarian Nordic A

¸ - /-&

Thank you. And good morning, and welcome to this conference call regarding Bavarian Nordic's acquisition of 2 commercial vaccines from GSK. My name is Rolf Sørensen. And with me today, I have our Chief Financial Officer, Henrik Juuel, as well as our President and CEO, Paul Chaplin.

Before we begin the presentation, I would like to read the following statements. This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside our control, but could cause actual results to differ materially from the results discussed. Forward-looking statements include statements regarding our short-term objectives and other changes, financial expectations and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot